By Josh White
Date: Tuesday 30 Jun 2026
(Sharecast News) - RUA Life Sciences narrowed its first-half post-tax loss to £203,000 from £635,000, it reported on Tuesday, as revenue rose 6.1% to £2.75m and adjusted EBITDA swung to a £76,000 profit from a £227,000 loss.
| Interim Results | 30-Jun-2026 | 07:00 | RNS |
| Holding(s) in Company | 02-Jun-2026 | 07:00 | RNS |
| Trading update for the 6-months ended 31/03/2026 | 22-May-2026 | 07:00 | RNS |
| Spinout and Completion of Financing of RSH | 12-May-2026 | 07:00 | RNS |
| Result of AGM | 17-Mar-2026 | 16:54 | RNS |
| Stalemate in legal dispute at AorTech | 30-Sep-2014 | The Herald |
| AIM hopes help Aortech to soar | 25-Nov-2011 | The Herald |
| AorTech surges on supply agreement | 19-May-2009 | The Herald |
| Director Dealings: Archial proves attractive | 13-Apr-2009 | Scotland on Sunday |
| AorTech founders sell shares to board | 07-Apr-2009 | The Herald |
| AorTech leads gainers on latest Scottish StockWa... | 04-Nov-2006 | The Scotsman |
| Smaller stock to watch | 26-Oct-2006 | Times |
| Reeling Plusnet at two-year low as broadband bat... | 08-Aug-2006 | Times |
| Vodafone is ringing a few alarm bells | 21-Jan-2006 | The Scotsman |
| Tomb Raider company takes a hit | 21-Jan-2006 | Guardian |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 27.00p |
| Change Today | -1.50p |
| % Change | -5.26 % |
| 52 Week High | 28.71 |
| 52 Week Low | 11.00 |
| Volume | 192,974 |
| Shares Issued | 62.06m |
| Market Cap | £16.76m |
| RiskGrade | 290 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| Time | Volume / Share Price |
| 14:44 | 35,000 @ 26.30p |
| 15:20 | 11,563 @ 26.10p |
| 14:55 | 2,150 @ 27.20p |
| 14:41 | 15,000 @ 27.20p |
| 12:18 | 500 @ 27.20p |
| CEO | William D Brown |
| CFO | Lachlan Smith |
You are here: research